GlassScriptPhysician profile
Leslie B Parent
NPI 1700044963
$592.67
in general payments reported to CMS, 2019-2025
21 companies · $33.51 in 2025
The $33.51 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $38.06 · 2021: $64.08 · 2022: $117 · 2023: $81.68 · 2024: $102 · 2025: $33.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $76.07 | 2021-2023 | Azstarys |
| Sanofi Pasteur INC. | $74.02 | 2022-2023 | |
| Amgen INC. | $52.39 | 2019 | |
| Pfizer INC. | $50.16 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.57 | 2021 | |
| Supernus Pharmaceuticals, INC. | $28.42 | 2021-2023 | Qelbree |
| Tris Pharma INC | $26.54 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.16 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $23.26 | 2024 | Fanapt |
| Ironshore Pharmaceuticals INC. | $22.15 | 2024 | |
| Sobi, INC | $22.09 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.39 | 2024 | Caplyta |
| Allergan, INC. | $18.80 | 2019 | |
| Lilly USA, LLC | $18.58 | 2024 | Zepbound, Mounjaro, Basaglar |
| Abbvie INC. | $17.13 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $15.22 | 2022 | |
| Neos Therapeutics, LP | $14.85 | 2019 | |
| Glaxosmithkline, LLC. | $14.81 | 2025 | Bexsero, Penmenvy |
| Dynavax Technologies Corporation | $13.14 | 2020 | |
| Shire North American Group INC | $12.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Parent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.